| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| amoxicillin (som amoxicillintrihydrat) 875 milligram och klavulansyra (som kaliumklavulanat) 125 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| karbidopa (som karbidopamonohydrat) 10 milligram och levodopa 100 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| karbidopa (som karbidopamonohydrat) 12,5 milligram och levodopa 50 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 250 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| amoxicillin (som amoxicillintrihydrat) 250 milligram och klavulansyra (som kaliumklavulanat) 125 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| amoxicillin (som amoxicillintrihydrat) 500 milligram och klavulansyra (som kaliumklavulanat) 125 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only articaine and epinephrine (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Enalapril and felodipine only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only lanolin and zinc oxide (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Cetirizine and pseudoephedrine only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only morphine and naltrexone (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Benzocaine and trimethobenzamide only product in rectal dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only benzocaine and trimethobenzamide (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Prednisolone and sulfacetamide only product in ocular dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Lanolin and zinc oxide only product in cutaneous dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only prednisolone and sulfacetamide (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only boric acid and salicylic acid (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Carmellose and hydroxyapatite only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Citric acid and potassium bicarbonate only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Carmellose and hydroxyapatite only product in parenteral dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only citric acid and potassium bicarbonate (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Fluorescein stain and oxybuprocaine only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Enalapril and felodipine only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing only fluorometholone and sulfacetamide (medicinal product) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Glyceryl trinitrate 2 mg buccal tablet |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Fluorometholone and sulfacetamide only product in ocular dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Benserazide and levodopa only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Benserazide 25 mg and levodopa 100 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing only polythiazide and prazosin in oral dose form (medicinal product form) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Polythiazide and prazosin only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Metformin and saxagliptin only product |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Metformin and saxagliptin only product in oral dose form |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrocortisone valerate 2 mg/g cutaneous ointment |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Glyceryl trinitrate 2 mg prolonged-release buccal tablet |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Methylphenidate hydrochloride 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 2 mg/mL ear solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| cetrimid 5 milligram/milliliter och klorhexidinglukonat (som klorhexidin) 500 mikrogram/milliliter, kutan lösning |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |